| scholarly article | Q13442814 |
| P50 | author | Catherine Stehman-Breen | Q114401735 |
| Brian R Kestenbaum | Q114407579 | ||
| Anne B. Newman | Q21401975 | ||
| Bruce M. Psaty | Q30429993 | ||
| Ronit Katz | Q30437553 | ||
| Stephen Seliger | Q58822334 | ||
| Russell P Tracy | Q86752125 | ||
| David S Siscovick | Q86839898 | ||
| Michael G Shlipak | Q87224063 | ||
| Mark J Sarnak | Q88732407 | ||
| P2093 | author name string | Linda F Fried | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| circulatory system | Q11068 | ||
| P304 | page(s) | 237-46 | |
| P577 | publication date | 2006-08-15 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease | |
| P478 | volume | 145 |
| Q56970799 | 2007 ESH‐ESC Guidelines for the management of arterial hypertension |
| Q56970511 | 2013 ESH/ESC Guidelines for the management of arterial hypertension |
| Q35098249 | A biomarker panel for peripheral arterial disease |
| Q34455130 | Albuminuria and the risk of incident stroke and stroke types in older adults |
| Q35838825 | Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. |
| Q50553806 | Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis |
| Q33961569 | Anemia is associated with the progression of white matter disease in older adults with high blood pressure: the cardiovascular health study |
| Q51172231 | Antihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis. |
| Q33691644 | Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules. |
| Q64997855 | Arterial Stiffness in Patients With Renal Transplantation; Associations With Co-morbid Conditions, Evolution, and Prognostic Importance for Cardiovascular and Renal Outcomes. |
| Q37887526 | Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage |
| Q34728350 | Assessment and modeling of routinely used biochemical laboratory data of healthy individuals and end-stage renal failure (ESRF) patients by three different chemometric methods. |
| Q88517025 | Association Between Cystatin C and 20-Year Cumulative Incidence of Hearing Impairment in the Epidemiology of Hearing Loss Study |
| Q46495930 | Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status |
| Q37412696 | Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality |
| Q34747057 | Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q37696905 | Association of body mass index, waist circumference, and metabolic syndrome with serum cystatin C in a Chinese population |
| Q37001231 | Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years |
| Q33562005 | Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). |
| Q53963735 | Association of cystatin C and depression in healthy elders: the health, aging and body composition study. |
| Q37405422 | Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study |
| Q33932292 | Association of cystatin C with adverse outcomes. |
| Q33276760 | Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study |
| Q33407103 | Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study |
| Q36667225 | Association of mild to moderate kidney dysfunction and coronary calcification |
| Q37290740 | Association of renal function with cardiac calcifications in older adults: the cardiovascular health study |
| Q43057769 | Association of serum cystatin C with pulse wave velocity, but not pressure wave reflection, in subjects with normal renal function or mild chronic kidney disease |
| Q36280359 | Associations between kidney function and subclinical cardiac abnormalities in CKD. |
| Q34625940 | Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q34936957 | Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly women |
| Q34822730 | Bidirectional association of retinal vessel diameters and estimated GFR decline: the Beaver Dam CKD Study |
| Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
| Q37081787 | Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective |
| Q38079565 | Biomarkers in atrial fibrillation: a clinical review |
| Q28087304 | Biomarkers in chronic kidney disease, from kidney function to kidney damage |
| Q37893446 | Biomarkers in chronic kidney disease: a review |
| Q37323794 | Biomarkers related to aging in human populations. |
| Q51725868 | Blood Selenium Concentration and Blood Cystatin C Concentration in a Randomly Selected Population of Healthy Children Environmentally Exposed to Lead and Cadmium. |
| Q37671786 | Body mass index and early kidney function decline in young adults: a longitudinal analysis of the CARDIA (Coronary Artery Risk Development in Young Adults) study |
| Q87289944 | Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease |
| Q34989544 | Cardiovascular and Renal Links along the Cardiorenal Continuum |
| Q37691417 | Cardiovascular biomarkers and their utility in the older adult |
| Q37454373 | Cardiovascular risk and management in chronic kidney disease |
| Q42059457 | Central blood pressure and chronic kidney disease progression. |
| Q37449550 | Change in cardiovascular risk factors with progression of kidney disease |
| Q36911521 | Chronic kidney disease (CKD) in the elderly -- a geriatrician's perspective |
| Q35030634 | Chronic kidney disease in octogenarians |
| Q44821800 | Chronic kidney disease: Cystatin-C-based eGFR: what is it telling us? |
| Q36925534 | Clinical associations between renal dysfunction and vascular events: A literature review |
| Q37259589 | Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study) |
| Q34736194 | Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America |
| Q33608612 | Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians |
| Q59050709 | Comparison of Different Measures of Fat Mass and Their Association with Serum Cystatin C Levels |
| Q40725063 | Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome. |
| Q34267914 | Comparison of estimated glomerular filtration rate by the chronic kidney disease epidemiology collaboration (CKD-EPI) equations with and without Cystatin C for predicting clinical outcomes in elderly women |
| Q37574064 | Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women |
| Q39447438 | Contribution of cystatin C gene polymorphisms to cerebral white matter lesions |
| Q46476309 | Correlation of serum ribavirin concentration with pretreatment renal function estimates in patients with chronic hepatitis C receiving combination antiviral therapy with peginterferon and ribavirin |
| Q58549088 | Creatinine- and Cystatin C-Based Incidence of Chronic Kidney Disease and Acute Kidney Disease in AKI Survivors |
| Q92663850 | Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study |
| Q35658295 | Cystatin C Is Not Causally Related to Coronary Artery Disease |
| Q37076093 | Cystatin C Predicts Incident Cardiovascular Disease in Twins |
| Q51267068 | Cystatin C and albuminuria as predictors of long-term allograft outcomes in kidney transplant recipients. |
| Q34959486 | Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q36323314 | Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate |
| Q43180532 | Cystatin C and cardiac hypertrophy in primary hypertension. |
| Q43119836 | Cystatin C and cardiovascular risk in the general population |
| Q34614924 | Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q35661812 | Cystatin C and cognitive impairment 10 years later in older women |
| Q24685074 | Cystatin C and risk of heart failure in the Physicians' Health Study (PHS) |
| Q36821470 | Cystatin C and risk of hip fractures in older women |
| Q33855997 | Cystatin C and sudden cardiac death risk in the elderly |
| Q51870668 | Cystatin C as a filtration marker--haemodialysis patients expose its strengths and limitations. |
| Q36150140 | Cystatin C as a predictive marker of renal dysfunction and mid-term outcomes following off-pump coronary artery bypass grafting |
| Q47264158 | Cystatin C as a predictor of cardiovascular outcomes in a hypertensive population |
| Q37616789 | Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease |
| Q51621252 | Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III. |
| Q34457290 | Cystatin C identifies chronic kidney disease patients at higher risk for complications |
| Q37155015 | Cystatin C in Acute Coronary Syndrome |
| Q90108422 | Cystatin C is a useful predictor of early neurological deterioration following ischaemic stroke in elderly patients with normal renal function |
| Q51474303 | Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth. |
| Q35746107 | Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus |
| Q36094689 | Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study |
| Q24635177 | Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study |
| Q46030370 | Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome. |
| Q37703935 | Cystatin C, CRP, log TG/HDLc and metabolic syndrome are associated with microalbuminuria in hypertension |
| Q33830165 | Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds |
| Q35189962 | Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons |
| Q37364907 | Cystatin C, albuminuria, and mortality among older adults with diabetes. |
| Q42803609 | Cystatin C, creatinine, and albuminuria: bringing risk into 3 dimensions |
| Q36869663 | Cystatin C--a paradigm of evidence based laboratory medicine. |
| Q35658762 | Cystatin C: An alternative dialysis adequacy marker in high flux hemodialysis |
| Q37856794 | Cystatin C: a step forward in assessing kidney function and cardiovascular risk |
| Q28534470 | Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? |
| Q38162490 | Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus |
| Q48173200 | Detection of a Peptide Biomarker by Engineered Yeast Receptors. |
| Q36971461 | Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality |
| Q35106599 | Development and validation of risk index for cognitive decline using blood-derived markers |
| Q33654021 | Diminished Renal Function and the Incidence of Heart Failure |
| Q36119367 | Effect of Demographics on Excretion of Key Urinary Factors Related to Kidney Stone Risk |
| Q42126473 | Effect of hemodialysis on circulating cystatin c levels in patients with end stage renal disease |
| Q46191661 | Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism |
| Q34836097 | Emerging biomarkers in heart failure and cardiac cachexia |
| Q33978466 | Epidemiology of chronic kidney disease in heart failure |
| Q46223222 | Epidemiology of chronic kidney disease: results from a population of older adults in Germany |
| Q36495082 | Estimated GFR and Subsequent Higher Left Ventricular Mass in Young and Middle-Aged Adults With Normal Kidney Function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study |
| Q37325092 | Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine |
| Q34870809 | Estimated GFR associates with cardiovascular risk factors independently of measured GFR. |
| Q34338563 | Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women |
| Q51122936 | Estimated glomerular filtration rate is associated with both arterial stiffness and N-terminal pro-brain natriuretic peptide in newly diagnosed hypertensive patients. |
| Q37276263 | Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study |
| Q24652643 | Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD |
| Q34152092 | Estimation of Glomerular Filtration Rate Based on Serum Cystatin C versus Creatinine in a Uruguayan Population. |
| Q36020086 | Factors other than glomerular filtration rate affect serum cystatin C levels |
| Q36095111 | Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). |
| Q33988990 | Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study |
| Q46119552 | Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults |
| Q35032801 | Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. |
| Q51539273 | Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. |
| Q34361219 | Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study |
| Q39748064 | How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis |
| Q57448723 | Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty |
| Q47325664 | Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke |
| Q59793783 | Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: A nationwide population-based cohort study |
| Q41454338 | Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity |
| Q35976473 | Insulin resistance, cystatin C, and mortality among older adults |
| Q38966669 | Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol? |
| Q42587254 | Is Cystatin C an Important Prognostic Marker Independent of Renal Function? |
| Q33953345 | Is renal function associated with early age-related macular degeneration? |
| Q33806588 | Kidney function and cognitive health in older adults: the Cardiovascular Health Study |
| Q46783054 | Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study |
| Q37518114 | Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars |
| Q33804430 | Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis |
| Q35576334 | Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). |
| Q37285963 | Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. |
| Q33925821 | Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula |
| Q34238467 | Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study |
| Q33904523 | Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients |
| Q38651014 | Lack of association between cystatin C and different coronary atherosclerotic manifestations. |
| Q37002467 | Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA) |
| Q35661455 | Letter: the prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital (diabetes metab j 2011;35:543-50). |
| Q36667003 | Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis |
| Q33829301 | LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells |
| Q40572760 | Low glomerular filtration rate as an associated risk factor for sarcopenic muscle strength: is creatinine or cystatin C-based estimation more relevant? |
| Q51036859 | Lower glomerular filtration rate is associated with higher systemic vascular resistance in patients without prevalent kidney disease. |
| Q86978330 | Male Gender and Body Mass Index Are Associated With Hypertension and Reduced Kidney Function 5 or More Years After Living Kidney Donation |
| Q34629623 | Metabolic abnormalities are present in adults with elevated serum cystatin C |
| Q34725449 | Metabolic syndrome and renal injury |
| Q34985147 | Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study |
| Q37367733 | Method of glomerular filtration rate estimation affects prediction of mortality risk |
| Q33819382 | Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis |
| Q37780943 | National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events |
| Q43202927 | Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial |
| Q37588884 | Noncommunicable disease in rural India: Are we seriously underestimating the risk? The Nallampatti noncommunicable disease study |
| Q38864815 | Novel biomarkers with potential for cardiovascular risk reclassification |
| Q38882637 | OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES. |
| Q24607254 | Overweight, obesity, and elevated serum cystatin C levels in adults in the United States |
| Q37883007 | Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis |
| Q37163332 | Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study |
| Q38669818 | Predicting acute kidney injury: current status and future challenges |
| Q55149583 | Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease. |
| Q59049724 | Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography |
| Q35175419 | Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. |
| Q37316036 | Prevalence of Reduced Kidney Function by Estimated Glomerular Filtration Rate Using an Equation Based on Creatinine and Cystatin C in Metabolic Syndrome and Its Components in Korean Adults. |
| Q35846796 | Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels |
| Q37011127 | Principles of screening for chronic kidney disease |
| Q35134165 | Pulse-Wave Analysis of Optic Nerve Head Circulation Is Significantly Correlated with Kidney Function in Patients with and without Chronic Kidney Disease. |
| Q46983266 | RETRACTED: Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin |
| Q35108889 | Racial and ethnic differences in kidney function decline among persons without chronic kidney disease |
| Q35133148 | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis |
| Q35828786 | Racial variation in the relationship of anemia with mortality and mobility disability among older adults |
| Q43115602 | Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit |
| Q33887287 | Rapid kidney function decline and mortality risk in older adults |
| Q33402590 | Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis |
| Q44971342 | Relationship between body mass index and high cystatin levels among US adults. |
| Q33905277 | Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes |
| Q38690952 | Relationship between sensorimotor peripheral nerve function and indicators of cardiovascular autonomic function in older adults from the Health, Aging and Body Composition Study |
| Q37615466 | Relationship between serum cystatin C and polycystic ovary syndrome |
| Q40105964 | Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. |
| Q33297377 | Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review |
| Q41811725 | Role of serum cystatin-C and beta-2 microglobulin as early markers of renal dysfunction in children with beta thalassemia major |
| Q33639802 | Screening for chronic kidney disease in HIV-infected patients |
| Q35983519 | Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate |
| Q35799948 | Serum Cystatin C for the Diagnosis of Acute Kidney Injury in Patients Admitted in the Emergency Department |
| Q36241451 | Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes |
| Q90281720 | Serum Levels of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP), and Cardiac Function in Patients with Unstable Angina Pectoris |
| Q37179085 | Serum cystatin C and the risk of Alzheimer disease in elderly men |
| Q83327450 | Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis |
| Q34940161 | Serum cystatin C is a determinant of central pressure augmentation index measured by oscillometric method in renal transplant recipients |
| Q47638003 | Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus |
| Q45973807 | Serum cystatin C: a useful marker of kidney function in very old people. |
| Q37140664 | Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women |
| Q47586080 | Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial |
| Q42839516 | Special considerations in the management of chronic kidney disease in the elderly |
| Q34447671 | Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure |
| Q35165510 | Systematic shifts in cystatin C between 2006 and 2010. |
| Q36492773 | The association between elevated cystatin C levels with myocardial infarction: a meta-analysis |
| Q37305999 | The differential association of kidney dysfunction with small and large arterial elasticity: the multiethnic study of atherosclerosis |
| Q34210655 | The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population |
| Q35983439 | The impact of interlaboratory differences in cystatin C assay measurement on glomerular filtration rate estimation. |
| Q46343713 | The impact of occult renal failure on the cardiovascular risk stratification in an elderly population: the PREV-ICTUS study |
| Q44983748 | The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population |
| Q48586571 | The potential of cystatin-C to evaluate the prognosis of acute heart failure: A comparative study |
| Q42340184 | The prognostic importance of cystatin C in severe systolic dysfunction without chronic kidney disease |
| Q42772483 | The relationship of cystatin C, creatinine, estimated GFR, and cardiovascular events |
| Q48851857 | The role of cystatin C in vascular remodeling of balloon-injured abdominal aorta of rabbits |
| Q37045956 | Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates |
| Q37126287 | Update on cystatin C: incorporation into clinical practice |
| Q36677662 | Uric acid and incident kidney disease in the community |
| Q37684606 | Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS). |
| Q84122128 | Urinary spot albumin:creatinine ratio for documenting proteinuria in women with preeclampsia |
| Q42720721 | Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy |
| Q44781179 | What is the best treatment strategy for incidentally detected small renal masses? A decision analysis |
Search more.